FIG vs REGN · rev $274.2M vs P/E 14, rev $14.34B
Figma, Inc. (FIG) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Figma, Inc. (FIG) is a software - application company listed on NYSE.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported FIG revenue for 2025-09-30 was $274.2M. Net income was -$1.10B. Revenue was up 9.8% from 2025-06-30 to 2025-09-30. FIG currently screens at market cap $9.56B.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
FIG currently screens at market cap $9.56B. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the FIG and REGN stock pages for the full models.
Not investment advice.